The U.S. is set to receive enough doses of the three approved vaccines by the middle of May to cover all adults. The surplus would ensure supply to cover young adults and children, pending the result of safety and efficacy trials. They could also be used as potential “boosters” to further protect against emerging virus variants, or be shared with allies overseas once Americans are protected.
US to buy 100 million additional doses of Johnson & Johnson COVID-19 vaccine
